Jasper Therapeutics, Inc. Profile Avatar - Palmy Investing

Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engine…

Biotechnology
US, Redwood City [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Jasper Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of JSPR's Analysis
CIK: 1788028 CUSIP: 471871103 ISIN: US4718712023 LEI: - UEI: -
Secondary Listings
JSPR has no secondary listings inside our databases.